Biodefense

In August 2026, BARDA exercised a $36.9 million option under a significant contract with Shionogi Inc. for Fetroja, an antibiotic targeting drug-resistant infections. This contract, part of Project BioShield, underlines a robust federal commitment to enhancing medical countermeasures against biothreats, creating opportunities for suppliers in the healthcare sector.

The U.S. European Command's Apollo's Chariot 2026 Exercise focused on improving biodefense readiness. This initiative signals robust procurement opportunities for contractors specializing in medical logistics and interagency coordination related to biological threats.

SIGA Technologies remains engaged with U.S. federal agencies and international governments to secure procurement contracts for its antiviral product TPOXX. The fluctuating demand driven by public health priorities requires agile procurement strategies, underscoring the significance of timing in contract renewals and stockpile purchases for contractors and suppliers operating in this sector.